Panel urges strong warning for epilepsy drugs

July 7, 2008 2:05:01 PM PDT
Federal health officials want epilepsy drugs to carry a so-called black box warning cautioning about the risk of suicidal thoughts and behaviors.

The announcement comes days ahead of an FDA advisory panel meeting to discuss concerns about the drugs. Last month a federal report concluded epilepsy drugs are associated with a higher risk of suicidal tendencies.

An FDA spokesman says the agency is proposing the strong black box warning based on that analysis but will still seek the panel's input.